A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis
Superparamagnetic iron oxide nanoparticles with well-integrated multimodality imaging properties have generated increasing research interest in the past decade, especially when it comes to the targeted imaging of tumors. Bevacizumab (BCZM) on the other hand is a well-known and widely applied monoclo...
Main Authors: | Charalampos Tsoukalas, Dimitrios Psimadas, George A. Kastis, Vassilis Koutoulidis, Adrian L. Harris, Maria Paravatou-Petsotas, Maria Karageorgou, Lars R. Furenlid, Lia A. Moulopoulos, Dimosthenis Stamopoulos, Penelope Bouziotis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fchem.2018.00224/full |
Similar Items
-
Design and fabrication of a preclinical adaptive SPECT imaging system : AdaptiSPECT
by: Chaix, Cécile, et al.
Published: (2014) -
Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
by: Maria-Argyro Karageorgou, et al.
Published: (2021-05-01) -
Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study
by: Papachristou, Maria, et al.
Published: (2017) -
High-Resolution Gamma-Ray Imaging with Columnar Scintillators and CCD/CMOS Sensors, and FastSPECT III: A Third-Generation Stationary SPECT Imager
by: Miller, Brian William
Published: (2011) -
ROC study and SUV threshold using quantitative multi-modal SPECT for bone imaging
by: A. H. Vija, et al.
Published: (2019-06-01)